Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial

Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, single-arm clinical trial

Not available.

Saved in:
Bibliographic Details
Main Authors: Morag Griffin, Shreyans Gandhi, Richard J. Kelly, Talha Munir, Roochi Trikha, Eden Hicks, Deepak Jain, Masayo Ogawa, Ji Yu, Petra Muus, Austin G. Kulasekararaj
Format: Article
Language:English
Published: Ferrata Storti Foundation 2024-11-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/11846
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Not available.
ISSN:0390-6078
1592-8721

Similar Items